These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7375794)

  • 21. Cell production rates in human tissues and tumours and their significance. Part II: clinical data.
    Rew DA; Wilson GD
    Eur J Surg Oncol; 2000 Jun; 26(4):405-17. PubMed ID: 10873364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [What's new about microsatellite instability significance in human carcinogenesis?].
    Vaurs C; Bignon YJ
    Bull Cancer; 1997 Nov; 84(11):1061-71. PubMed ID: 9536988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proliferation markers as a tool in oncological neuropathology.
    Taus V
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1995; 38(4):145-65. PubMed ID: 8693281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Argyrophilic proteins in the regions of nucleolar organizers are markers of cell proliferation rate].
    Raĭkhlin NT; Bukaeva IA; Probatova NA; Smirnov EA
    Arkh Patol; 2006; 68(3):47-51. PubMed ID: 16830627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A phenomenological approach to the simulation of metabolism and proliferation dynamics of large tumour cell populations.
    Chignola R; Milotti E
    Phys Biol; 2005 Mar; 2(1):8-22. PubMed ID: 16204852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic significance of DNA ploidy and proliferation in 309 colorectal carcinomas as determined by two-color multiparametric DNA flow cytometry.
    Zarbo RJ; Nakhleh RE; Brown RD; Kubus JJ; Ma CK; Mackowiak P
    Cancer; 1997 Jun; 79(11):2073-86. PubMed ID: 9179053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High telomerase activity is associated with cell cycle deregulation and rapid progression in endometrioid adenocarcinoma of the uterus.
    Bonatz G; Frahm SO; Klapper W; Helfenstein A; Heidorn K; Jonat W; Krupp G; Parwaresch R; Rudolph P
    Hum Pathol; 2001 Jun; 32(6):605-14. PubMed ID: 11431715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oncogenes, self-renewal and cancer.
    Clarke MF
    Pathol Biol (Paris); 2006 Mar; 54(2):109-11. PubMed ID: 16524671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Importance of proliferation markers in gastrointestinal carcinoid tumors: a clinicopathologic study.
    Sökmensüer C; Gedikoglu G; Uzunalimoglu B
    Hepatogastroenterology; 2001; 48(39):720-3. PubMed ID: 11462912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell cycle and proliferation markers in neuroepithelial tumors.
    Cavalla P; Schiffer D
    Anticancer Res; 1997; 17(6B):4135-43. PubMed ID: 9428347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer growth and its inhibition in terms of coherence.
    Popp FA
    Electromagn Biol Med; 2009; 28(1):53-60. PubMed ID: 19337895
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and prognostic significance of Ki-67 and proliferating cell nuclear antigen expression in childhood primitive neuroectodermal brain tumors.
    Bodey B; Bodey B; Gröger AM; Siegel SE; Kaiser HE
    Anticancer Res; 1997; 17(1A):189-96. PubMed ID: 9066650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apoptotic markers in cancer.
    Holdenrieder S; Stieber P
    Clin Biochem; 2004 Jul; 37(7):605-17. PubMed ID: 15234242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of metallothioneins in tumor cells.
    Dziegiel P
    Pol J Pathol; 2004; 55(1):3-12. PubMed ID: 15195701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathobiology and clinical significance of molecular genetic findings in childhood tumors.
    Rubnitz JE; Downing JR; Crist WM
    Adv Pediatr; 1998; 45():315-36. PubMed ID: 9742307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tpot and head and neck cancer: where are we now?
    Wilson GD
    Anticancer Res; 1998; 18(6B):4801-5. PubMed ID: 9891560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Study methods of cellular kinetics and their application in cancerology].
    Najean Y
    Actual Odontostomatol (Paris); 1980; 34(129):73-9. PubMed ID: 7386250
    [No Abstract]   [Full Text] [Related]  

  • 38. A generalised age- and phase-structured model of human tumour cell populations both unperturbed and exposed to a range of cancer therapies.
    Basse B; Ubezio P
    Bull Math Biol; 2007 Jul; 69(5):1673-90. PubMed ID: 17361361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell proliferation kinetics in human tumor xenografts measured with iododeoxyuridine labeling and flow cytometry: a study of heterogeneity and a comparison between different methods of calculation and other proliferation measurements.
    Perez LA; Dombkowski D; Efird J; Preffer F; Suit HD
    Cancer Res; 1995 Jan; 55(2):392-8. PubMed ID: 7812972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic factors in survival of patients with stage Ta and T1 bladder urothelial tumors: the role of G1-S modulators (p53, p21Waf1, p27Kip1, cyclin D1, and cyclin D3), proliferation index, and clinicopathologic parameters.
    Lopez-Beltran A; Luque RJ; Alvarez-Kindelan J; Quintero A; Merlo F; Requena MJ; Montironi R
    Am J Clin Pathol; 2004 Sep; 122(3):444-52. PubMed ID: 15362377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.